Conflict of Interest Disclosures: Dr D.J. Ramsey reported receiving personal fees from Regeneron Pharmaceuticals and Beaver-Visitec International Inc outside the submitted work. Dr Kosiborod reported receiving institutional support from grants from AstraZeneca, Boehringer Ingelheim, and Pfizer; personal fees from AstraZeneca, Boehringer Ingelheim, Pfizer, 35Pharma, Alnylam, Amgen, Applied Therapeutics, Arrowhead Pharmaceuticals, Bayer, Corcept Therapeutics, Cytokinetics, Dexom, Eli Lilly, Esperion Therapeutics, Imbria Therapeutics, Janssen, Lexicon Pharmaceuticals, Merck, NoroNordisk, Pharmacosmos, Regeneron Pharmaceuticals, Roche, Sanofi, scPharmaceuticals, Structure Therapeutics, Vifor Pharma, and Youngene Therapeutics; stock options held in Artera Health and Saghmos Therapeutics; and salary from AstraZeneca Research and Development outside the submitted work. Dr Fonarow reported receiving personal fees from Abbot, AstraZeneca, Amgen, Bayer, Boehringer Ingelheim, Cytokinetics, Eli Lilly, Johnson & Johnson, Medtronic, Merck, Novartis, and Pfizer outside the submitted work. Dr Nohria reported receiving personal fees from AstraZeneca and Takeda Oncology and grants from Bristol Myers Squibb outside the submitted work. Dr Butler reported receiving personal fees from Abbott, Adaptyx, American Regent, Amgen, AskBio, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Cardiac Dimension, Cardior, CSL Vifor, CVRx, Cytokinetics, Daxor, Diastol, Edwards, Element Sciences, Faraday, Idorsia, Impulse Dynamics, Imbria, Innolife, Intellia, Inventiva, Levator, Lexicon, Eli Lilly, Mankind, Medtronic, Merck, New Amsterdam, Novartis, NovoNordisk, Pfizer, Pharmacosmos, Pharmain, Prolaio, Pulnovo, Regeneron Pharmaceuticals, Renibus, Reprieve, Roche, Rycarma, Saillent, Salamandra, Salubris, scPharmaceuticals, SQ Innovation, Secretome, Sequanna, Transmural, TekkunLev, Tenex, Tricog, Ultromic, Vera, and Zoll outside the submitted work. No other disclosures were reported.
PubMed
